BRUNO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 577
EU - Europa 282
AS - Asia 210
AF - Africa 9
Totale 1.078
Nazione #
US - Stati Uniti d'America 574
IT - Italia 128
SG - Singapore 123
IE - Irlanda 57
CN - Cina 55
UA - Ucraina 29
SE - Svezia 26
IL - Israele 11
DE - Germania 9
ID - Indonesia 9
NG - Nigeria 8
FR - Francia 7
RS - Serbia 6
BE - Belgio 5
HK - Hong Kong 5
CA - Canada 3
ES - Italia 3
GB - Regno Unito 3
IN - India 2
KR - Corea 2
NL - Olanda 2
PL - Polonia 2
BG - Bulgaria 1
CH - Svizzera 1
FI - Finlandia 1
GR - Grecia 1
IR - Iran 1
RO - Romania 1
SC - Seychelles 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 1.078
Città #
Chandler 109
Singapore 109
Santa Clara 69
Dublin 57
Turin 38
Columbus 28
Nyköping 26
Medford 17
Princeton 16
Ashburn 13
Beijing 12
Tel Aviv 11
Jakarta 9
Abuja 8
Bari 7
Hangzhou 7
Boston 6
Milan 6
New York 6
Torino 6
Ann Arbor 5
Brussels 5
Guangzhou 5
Houston 5
Novi Sad 5
Moncalieri 4
Pisa 4
Fremont 3
Jacksonville 3
London 3
Norwalk 3
Rome 3
Sirignano 3
Toronto 3
Wilmington 3
Campobasso 2
Catanzaro 2
Chengdu 2
Dearborn 2
Fairfield 2
Krakow 2
Nanjing 2
Paris 2
Rivoli 2
San Mauro Torinese 2
Seoul 2
Silea 2
Villeurbanne 2
Amsterdam 1
Bangalore 1
Barcelona 1
Belgrade 1
Boardman 1
Central District 1
Cerritos 1
Cormeilles-en-Parisis 1
Deiva Marina 1
Falkenstein 1
Falls Church 1
Genova 1
Grafing 1
Grugliasco 1
Guiyang 1
Gunzenhausen 1
Harbin 1
Hebei 1
Istanbul 1
Lainate 1
Lappeenranta 1
Los Angeles 1
Madrid 1
Mountain View 1
Munich 1
Nuremberg 1
Orio Canavese 1
Ovada 1
Saint Louis 1
San Mateo 1
Sofia 1
Taramani 1
Upper Marlboro 1
Vicenza 1
Vigo 1
Wenzhou 1
Woodbridge 1
Totale 680
Nome #
Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study. 67
NCOG-19. PROGNOSTIC FACTORS IN ELDERLY PATIENTS WITH GLIOBLASTOMA: A RETROSPECTIVE INSTITUTIONAL SERIES OF 160 PATIENTS 66
Ependymoma: Evaluation and Management Updates 66
IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroups 59
Effects of Circadian Phase Tailored Light Therapy on Sleep, Mood, and Cognition in Alzheimer’s Disease: Preliminary Findings in a Pivotal Study 58
Elderly Gliobastoma Patients: The Impact of Surgery and Adjuvant Treatments on Survival. A Single Institution Experience 53
Leptomeningeal metastases from non-small cell lung cancer: state of the art and recent advances 52
Glioblastoma in the Elderly: Review of Molecular and Therapeutic Aspects 52
Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand? 51
What Have We Learned from Recent Clinical Studies in Low-Grade Gliomas? 50
Prognostic Analysis of the IDH1 G105G (rs11554137) SNP in IDH-Wildtype Glioblastoma 50
Neratinib and Capecitabine for the Treatment of Leptomeningeal Metastases from HER2-Positive Breast Cancer: A Series in the Setting of a Compassionate Program 47
Long-term survival of a sacro-coccygeal myxopapillary ependymoma with extra-neural metastases: case report and review of the literature 44
Pembrolizumab-Induced Isolated Cranial Neuropathy: A Rare Case Report and Review of Literature 40
Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study 37
Targeted therapies in rare brain tumours 35
Current and Future Drugs for Brain Tumors Treatment 34
Systemic Therapy for Lung Cancer Brain Metastases 34
Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy? 33
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter? 25
Association of Clinical, Tumor, and Treatment Characteristics With Seizure Control in Patients With IDH1/2-Mutant Lower-Grade Glioma 20
Newly diagnosed glioblastoma: A review on clinical management 20
Effects of Levetiracetam and Lacosamide on survival and seizure control in IDH-wild type glioblastoma during temozolomide plus radiation adjuvant therapy 19
Epilepsy in gliomas: recent insights into risk factors and molecular pathways 18
The Impact of Lateral Ventricular Opening in the Resection of Newly Diagnosed High-Grade Gliomas: A Single Center Experience 16
Neurotoxicity from Old and New Radiation Treatments for Brain Tumors 16
Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience 16
[18F]DOPA PET for lesion definition and contouring using different thresholds in patients with gliomas 14
Advances in molecular and imaging biomarkers in lower-grade gliomas 11
A novel scoring system proposal to guide surgical treatment indications for high grade gliomas in elderly patients: DAK-75 10
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study 9
TERT promotor status does not add prognostic information in IDH-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO resect group 7
Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group 5
Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: A complementary report of the RANO resect group 4
Totale 1.138
Categoria #
all - tutte 6.065
article - articoli 0
book - libri 0
conference - conferenze 271
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.336


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016 0 0 0 0 1 4 2 1 1 1 3 3
2020/202121 1 2 1 0 8 3 0 1 1 3 0 1
2021/2022179 0 0 7 2 3 18 6 13 3 34 53 40
2022/2023374 25 27 14 38 47 74 27 19 50 8 26 19
2023/2024160 19 35 12 10 5 15 3 10 1 12 13 25
2024/2025367 4 98 44 95 126 0 0 0 0 0 0 0
Totale 1.138